High-intensity Functional Training on Functional and Cognitive Performance in People with Parkinson's Disease.
Effectiveness of a High-intensity Functional Training (HIFT) Program on Functional and Cognitive Performance in People with Parkinson's Disease.
1 other identifier
interventional
34
1 country
1
Brief Summary
Parkinson's disease (PD) is a progressive and chronic neurodegenerative disease, which presents signs and symptoms both motor (impaired gait, posture, balance, etc.) and cognitive (memory loss, dementia, etc.), all of which are causing disability and assuming a high economic cost. Currently, there are already certain authors who have shown how a high-intensity interval training (HIIT) protocol produces improvements in cognitive and physical performance in healthy adults6 and in people with multiple sclerosis. However, another modality has been created, such as high-intensity functional training (HIFT), which can benefit different populations, both healthy and pathological, due to the multimodal nature of the exercises. Thanks to multimodality, more aspects such as agility, coordination and precision of movements are worked on compared to unimodal HIIT programs that make this relevant work difficult in a person's daily life. The current study aims to demonstrate the effectiveness of a HIFT training protocol in a specific population, such as people with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Mar 2022
Typical duration for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2022
CompletedFirst Submitted
Initial submission to the registry
March 11, 2025
CompletedFirst Posted
Study publicly available on registry
March 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedMarch 17, 2025
February 1, 2025
9 months
March 11, 2025
March 11, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Short physical performance battery (SSPB)
Functional performance evaluation.
10 minutes
Trail Making Test A y B
Evaluation of visual search, scanning, processing speed, mental flexibility and executive functions.
15 minutes
Secondary Outcomes (5)
SF-12 Health Questionnaire
10 minutes
Barthel index
10 minutes
fall risk assessment scale
5 minutes
2-minute walk test (2-MWT)
5 minutes
Mini Mental State Examination
20 minutes
Other Outcomes (1)
The Borg Scale
2 minutes
Study Arms (2)
Experimental group
EXPERIMENTALThe experimental group will perform a high-intensity functional training program twice a week for 10 weeks.
Control Group
NO INTERVENTIONThe control group will continue to carry out their physical and cognitive exercise routine during the week, recording their activity in days and sessions.
Interventions
The pillar of rehabilitation will be based on high intensity functional training. 45-minute sessions divided into 5 minutes of warm-up, 35 minutes of functional exercises, and 5 minutes of going back to bed and cooling down. The 35 minutes of exercises were divided into 3 categories: lower extremity exercises, upper extremity exercises, and static and dynamic coordination and balance exercises. Each category will consist of 3 exercises per session, performing 2-3 series with a maximum of repetitions of 10-RM. The progression of the load will be progressively increased in weeks 3, 5 and 8 between 40-60% of the 1-RM.
Eligibility Criteria
You may qualify if:
- Diagnosis of Parkinson's disease.
- Stage I or II (Hoehn - Yahr Scale).
- Age between 45 and 80 years.
- Independent ambulation for 10 consecutive minutes.
- Regular physical exercise.
You may not qualify if:
- Medical contraindication for physical activity, deafness or limited hearing and very low vision or blind.
- Vestibular disorders that compromise balance.
- Psychotic or severe cognitive disorder.
- Decompensation or changes in medication.
- Surgical intervention in the last 6 months.
- Sedentary persons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Valencia
Valencia, Valencia, 46010, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 11, 2025
First Posted
March 17, 2025
Study Start
March 14, 2022
Primary Completion
November 30, 2022
Study Completion
April 30, 2025
Last Updated
March 17, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share